Balanced modulation of striatal activation from D2/D3 receptors in caudate and ventral striatum: Disruption in cannabis abusers

Human Brain Mapping

Volumn 36, Issue 8, 2015, Pages 3154-3166

  Tomasi, Dardo ^a   Wang, Gene Jack ^a   Volkow, Nora D ^a,b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

dopamine; functional magnetic resonance imaging; positron emission tomography; raclopride; reaction time; reward; sensorimotor

Indexed keywords

CANNABIS; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE C 11; DOPAMINE RECEPTOR BLOCKING AGENT; RACLOPRIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANNABIS ADDICTION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; NEUROMODULATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REACTION TIME; SENSORIMOTOR FUNCTION; TASK PERFORMANCE; VELOCITY; VENTRAL STRIATUM; BRAIN MAPPING; DRUG EFFECTS; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SCINTISCANNING;

ADULT; BRAIN MAPPING; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; POSITRON-EMISSION TOMOGRAPHY; PSYCHOMOTOR PERFORMANCE; RACLOPRIDE; RADIOPHARMACEUTICALS; REACTION TIME; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 84930737803     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22834     Document Type: Article

References (50)

1. Adler A, Katabi S, Finkes I, Prut Y, Bergman H (2013): Different correlation patterns of cholinergic and GABAergic interneurons with striatal projection neurons. Front Syst Neurosci 7:47
2. Ames S, Grenard J, Stacy A, Xiao L, He Q, Wong S, Xue G, Wiers R, Bechara A (2013): Functional imaging of implicit marijuana associations during performance on an implicit association test (IAT). Behav Brain Res 256:494–502.
3. Asensio S, Romero M, Romero F, Wong C, Alia-Klein N, Tomasi D, Wang G, Telang F, Volkow N, Goldstein R (2010): Striatal dopamine d2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later. Synapse 64:397–402.
4. Averbeck B, Lehman J, Jacobson M, Haber S (2014): Estimates of projection overlap and zones of convergence within frontal-striatal circuits. J Neurosci 34:9497–9505.
5. Batalla A, Bhattacharyya S, Yucel M, Fusar-Poli P, Crippa JA, Nogue S, Torrens M, Pujol J, Farre M, Martin-Santos R (2013): Structural and functional imaging studies in chronic cannabis users: A systematic review of adolescent and adult findings. PLoS One 8:e55821
6. Bolla K, Eldreth D, Matochik J, Cadet J (2005): Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26:480–492.
7. Chang L, Yakupov R, Cloak C, Ernst T (2006): Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation. Brain 129:1096–1112.
8. Dodds C, Clark L, Dove A, Regenthal R, Baumann F, Bullmore E, Robbins T, Müller U (2009): The dopamine d2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology (Berl) 207:35–45.
9. Draganski B, Kherif F, Klöppel S, Cook P, Alexander D, Parker G, Deichmann R, Ashburner J, Frackowiak R (2008): Evidence for segregated and integrative connectivity patterns in the human basal ganglia. J Neurosci 28:7143–7152.
10. Filbey F, Yezhuvath U (2013): Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am J Drug Alcohol Abuse 39:382–391.
11. Filbey FM, Dunlop J (2014): Differential reward network functional connectivity in cannabis dependent and non-dependent users. Drug Alcohol Depend 140:101–111.
12. Filbey F, Dunlop J, Myers U (2013): Neural effects of positive and negative incentives during marijuana withdrawal. PLoS One 8:e61470
13. Filbey F, Schacht J, Myers U, Chavez R, Hutchison K (2009): Marijuana craving in the brain. Proc Natl Acad Sci USA 106:13016–13021.
14. Freud R, Littell R (2003): SAS System for Regression, 3rd ed. Cary, NC: SAS Institute and Wiley.
15. 3 receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans. J Neurosci 32:7316–7324.
16. Goldman M, Szucs-Reed R, Jagannathan K, Ehrman RW, Wang Z, Li Y, Suh J, Kampman K, O'Brien CP, Childress AR, Franklin TR (2013): Reward-related brain response and craving correlates of marijuana cue exposure: A preliminary study in treatment-seeking marijuana-dependent subjects. J Addict Med 7:8–16.
17. Grahn J, Parkinson J, Owen A (2008): The cognitive functions of the caudate nucleus. Prog Neurobiol 86:141–155.
18. Gruber S, Rogowska J, Yurgelun-Todd D (2009): Altered affective response in marijuana smokers: An FMRI study. Drug Alcohol Depend 105:139–153.
19. Haber S, Kim K, Mailly P, Calzavara R (2006): Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J Neurosci 26:8368–8376.
20. Kienast T, Siessmeier T, Wrase J, Braus D, Smolka M, Buchholz H, Rapp M, Schreckenberger M, Rösch F, Cumming P, Gruender G, Mann K, Bartenstein P, Heinz A (2008): Ratio of dopamine synthesis capacity to d2 receptor availability in ventral striatum correlates with central processing of affective stimuli. Eur J Nucl Med Mol Imaging 35:1147–1158.
21. King G, Ernst T, Deng W, Stenger A, Gonzales R, Nakama H, Chang L (2011): Altered brain activation during visuomotor integration in chronic active cannabis users: Relationship to cortisol levels. J Neurosci 31:17923–17931.
22. Kohno M, Ghahremani DG, Morales AM, Robertson CL, Ishibashi K, Morgan AT, Mandelkern MA, London ED (2015): Risk-taking behavior: dopamine D2/D3 receptors, feedback, and frontolimbic activity. Cereb Cortex 25:236–245.
23. Levy R, Friedman H, Davachi L, Goldman-Rakic P (1997): Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J Neurosci 17:3870–3882.
24. Logan J, Fowler J, Volkow N, Wolf A, Dewey S, Schlyer D, MacGregor R, Hitzemann R, Bendriem B, Gatley S, Christman D (1990): Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 10:740–747.
25. Lopez-Larson M, Rogowska J, Bogorodzki P, Bueler C, McGlade E, Yurgelun-Todd D (2012): Cortico-cerebellar abnormalities in adolescents with heavy marijuana use. Psychiatry Res 202:224–232.
26. McHaffie J, Stanford T, Stein B, Coizet V, Redgrave P (2005): Subcortical loops through the basal ganglia. Trends Neurosci 28:401–407.
27. O'Brien R (2007): A caution regarding rules of thumb for variance inflation factors. Quality Quantity 41:673–690.
28. Pessiglione M, Seymour B, Flandin G, Dolan R, Frith C (2006): Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 442:1042–1045.
29. Rosa-Neto P, Doudet D, Cumming P (2004): Gradients of dopamine D1- and d2/3-binding sites in the basal ganglia of pig and monkey measured by PET. Neuroimage 22:1076–1083.
30. Sander C, Hooker J, Catana C, Normandin M, Alpert N, Knudsen G, Vanduffel W, Rosen B, Mandeville J (2013): Neurovascular coupling to d2/d3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci USA 110:11169–11174.
31. Schweinsburg A, Schweinsburg B, Medina K, McQueeny T, Brown S, Tapert S (2010): The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs 42:401–412.
32. Schweinsburg A, Schweinsburg B, Nagel B, Eyler L, Tapert S (2011): Neural correlates of verbal learning in adolescent alcohol and marijuana users. Addiction 106:564–573.
33. Smith A, Longo C, Fried P, Hogan M, Cameron I (2010): Effects of marijuana on visuospatial working memory: An fMRI study in young adults. Psychopharmacology (Berl) 210:429–438.
34. Stelzel C, Fiebach C, Cools R, Tafazoli S, D'Esposito M (2013): Dissociable fronto-striatal effects of dopamine d2 receptor stimulation on cognitive versus motor flexibility. Cortex 49:2799–2811.
35. Tapert S, Schweinsburg A, Drummond S, Paulus M, Brown S, Yang T, Frank L (2007): Functional MRI of inhibitory processing in abstinent adolescent marijuana users. Psychopharmacology (Berl) 194:173–183.
36. Tomasi D, Volkow N (2013): Striatocortical pathway dysfunction in addiction and obesity: Differences and similarities. Crit Rev Biochem Mol Biol 48:1–19.
37. Tomasi D, Caparelli EC, Chang L, Ernst T (2005): fMRI-acoustic noise alters brain activation during working memory tasks. Neuroimage 27:377–386.
38. Tomasi D, Ernst T, Caparelli EC, Chang L (2006): Common deactivation patterns during working memory and visual attention tasks: An intra-subject fMRI study at 4 Tesla. Hum Brain Mapp 27:694–705.
39. Tziortzi A, Searle G, Tzimopoulou S, Salinas C, Beaver J, Jenkinson M, Laruelle M, Rabiner E, Gunn R (2011): Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of d3 signal and anatomy. Neuroimage 54:264–277.
40. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M, (2002): Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273–289.
41. Urban N, Slifstein M, Thompson J, Xu X, Girgis R, Raheja S, Haney M, Abi-Dargham A (2012): Dopamine release in chronic cannabis users: A [(11)c]raclopride positron emission tomography study. Biol Psychiatry 71:677–683.
42. Volkow N, Fowler J, Wang G, Dewey S, Schlyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf A (1993a): Reproducibility of repeated measures of Carbon-11-raclopride binding in the human brain. J Nucl Med 34:609–613.
43. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP (1993b): Decreased dopamine d2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169–177.
44. Volkow N, Gur R, Wang G, Fowler J, Moberg P, Ding Y, Hitzemann R, Smith G, Logan J (1998): Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155:344–349.
45. Volkow N, Tomasi D, Wang G, Telang F, Fowler J, Wang R, Logan J, Wong C, Jayne M, Swanson J (2009): Hyperstimulation of striatal d2 receptors with sleep deprivation: Implications for cognitive impairment. Neuroimage 45:1232–1240.
46. Volkow N, Wang G, Fowler J, Tomasi D, Telang F (2011): Addiction: Beyond dopamine reward circuitry. Proc Natl Acad Sci USA 108:15037–15042.
47. Volkow N, Baler R, Compton W, Weiss S (2014a): Adverse health effects of marijuana use. N Engl J Med 370:2219–2227.
48. Volkow N, Wang G, Telang F, Fowler J, Alexoff D, Logan J, Maynard J, Wong C, Tomasi D (2014b): Decreased dopamine brain reactivity in marijuana abusers: Association with negative emotionality and addiction severity. Proc Natl Acad Sci USA 111:E3149–E3156.
49. Wang G, Smith L, Volkow N, Telang F, Logan J, Tomasi D, Wong C, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler J (2011): Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry 17:918–925.
50. Wesley M, Hanlon C, Porrino L (2011): Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res 191:51–59.